Novo Nordisk’s Desert Hub for Wegovy Pill Signals Global Ambition, but Goldman Keeps Neutral Ratin
Danish drugmaker ships daily weight-loss pill to Gulf, Africa, and Central Asia from June 2026, leveraging no cold-chain…
Novo Nordisk’s AI Ambition and Workforce Whiplash
Novo Nordisk stock struggles as AI initiative GPT-Rosalind launches against a backdrop of revenue decline, patent expiry, and…